News
03.July 09Domainex collaborates with St George’s HospitalDomainex Ltd, St George’s University of London and the University of Manchester today announced that they are collaborating on a new drug discovery programme to provide a better treatment for asthma.
Click here to read the full press release.
03.July 09Domainex and Ark Therapeutics extend drug discovery agreementDomainex have announced an extension of its research agreement with Ark Therapeutics Group Ltd.
Click here to read the full press release.
11.May 09Venture investment in SIPPs - Do the MathsCareful research and informed decision-making can help greatly in using SIPPs to construct clients’ investment portfolios, control risk and boost growth.
Julian Hickman, Longbow Partner, discusses the benefits of venture investment within SIPPs in the Investment Adviser.
Read the full story online in the
Investment Adviser07.April 09Longbow’s Keith Powell in the Financial TimesLongbow Partner, and Polytherics CEO, Keith Powell was featured in the Financial Times today, describing investment in Biotech as ’in terms of employment and developing the economy, biotech is extremely good value for money".
Read the full story in the
FT Online.
06.April 09Longbow Launches SIPP Venture FundAXA Winterthur Wealth Management now offers the first SIPP venture fund from
Longbow Capital, via The One from Winterthur.
Read the full story in:
Citywire IFA OnlineAXA Winterthur’s Website FT OnlineOr
click here to read the full press release.
30.March 09Longbow Partner Ron Petersen
Boots Centre for Innovation in Swansea has appointed Ron Petersen as its new CEO.
Ron Petersen has been involved in the Boots Centre for Innovation since its inception in 2007, and has played an instrumental role in shaping the organisation’s business model. He has provided valuable advice on how to progress ideas received by the Centre, and is well-positioned to lead the Centre forward in 2009.
Visit
www.bootsinnovation.com/news.html to read more.
23.March 09Longbow reaches for the SkyRecent Investment - Sky Medical Longbow has just completed an investment into medical device company, Sky Medical. Sky Medical is commercializing a range of products based on technology developed at St Barts Hospital London; initially for the prevention of deep vein thrombosis but also for cardiovascular disease and improved circulation.
The investment will enable Sky Medical to launch its products into hospitals and pharmacies later this year. Sky Medical is the fourth investment in technology that can take advantage of Longbow’s relationship with the Boots Centre for Innovation.
Investors can access innovative life sciences companies like Sky Medical through the Longbow EIS Funds. For further information please call Julian Hickman or Nicola Robson on 020 7332 0320.
20.March 09Domainex and Breakthrough Breast CancerInnovative drug discovery company, Domainex, collaborates with Breakthrough Breast Cancer and Institute of Cancer Research on novel drug targets.
Please
click here to read the full press release.
11.March 09Longbow Newsletter Spring 2009Includes recent news from our Portfolio companies, details of recent investment, Sky Medical, and Longbow Partner Edward Rudd’s take on Healthcare and Venture Capital in a Recession.
Please
click here to download the newsletter.
26.February 09The Audacity of ScienceThe Times Leader argues the importance of scientific discovery in combatting the world’s major challenges including disease and climate change.
Click here to read the full story online.
21.February 09A head start - and a shot in the armThe Financial Times feature Longbow Capital in Matthew Vincent’s commentary on EIS investing.
Click here to read the full article online.
27.January 09Longbow Seminar SeriesLongbow will be running a seminar series to provide professional advisers with tax planning solutions for their clients. Please
click here for more information.
12.January 09Small scheme will shine on big dayLongbow partner, Julian Hickman, reports in
Fund Strategy magazine on the emergence of the Enterprise Investment Scheme and the positive effects it has had for companies and investors alike.
Click here to read the article.
01.December 08Hoping for Healthy ReturnsRon Petersen and Edward Rudd, partners at Longbow Capital, speak to growthbusiness.co.uk.
Please
click here to read the full story.
06.November 08Longbow invests in Biotronics 3DLongbow invests in Healthcare IT company Biotronics 3D.
Please
click here to read the full press release.
16.October 08BreastLight hold their first User SymposiumPWB Health held their first BreastLight User Symposium where they announced the feedback from their most recent user trials.
15.October 08Longbow announces new fundsLongbow is pleased to announce that they have launched two new EIS Funds:
The Approved EIS Fund and the Arrowhead EIS Fund both target a £10m raise and focus on growth areas within the healthcare, life science and wellbeing sectors.
Please
click here to read the full press release.
Please
click here to read about Longbow in the Investors Chronicle Online.
Please
click here to read about Longbow in the FT Adviser Online.
01.October 08Longbow Newsletter Autumn 2008Includes commentary from Cerno Capital, recent news from our portfolio companies, a news report from the BCI and the Final Word from Edward Beckett, Managing Partner.
Please
Click here to download the newsletter.
04.June 08Longbow company Domainex, secures £1 millionLongbow Capital has invested £1 million into Domainex.
Please
click here to read the full story.
23.May 08Destiny Pharma recieve national acclaimRead more in online articles in The
Telegraph,
The Independent and the
BBC website:
12.May 08Longbow invests in CyDen LtdLongbow and Unilever Ventures invest over £2m in CyDen Ltd.
Please
click here to read the full story.
21.April 08Longbow partner Ron Petersen speaks to Sky News about the world of NanotechnologyFollow the link below to watch Ron Petersen speaking on Sky News Technophile.
Technophile video - The world of Nanotechnology.01.April 08Longbow Spring Newsletter 2008Includes Company updates, a budget report and recent news from the Boots Centre for Innovation.
Please
click here to download the newsletter.
23.July 07Longbow invests in PWB HealthGLASGOW-BASED Polaroid spinout Wideblue has raised £1.25 million in venture capital funding and created a new company, PWB Health Limited, to develop health products and market them worldwide.
20.June 07Longbow Company, PolyTherics, raises over £2 millionLongbow Capital invests over £2 million into Biopharmaceutical company Polytherics.
Please
click here to read the full story.